Figure 1
From: Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1
Schematic representation of the recombinant fusion proteins used in this work. PinX1, the 328-aa full-length PinX1; PinX1C, the 74-aa C-terminal fragment of PinX1; PinX1N, the 142-aa N-terminal fragment of PinX1; PinX1/C/N, PinX1 or PinX1C, or PinX1N; 9R, nine arginine residues; G4S, four glycine residues and one serine residue; mBAFF, a soluble human BAFF mutant, in which amino acids 217–224 are replaced by two glycine residues.
